The results verified that risk score (HR=1.614 (95% CI: 1.199-2.173), p=0.002) and tumor stage (HR=1.838 (95% CI: 1.228-2.750), p=0.003) were independent risk factors for PFS in the BRAF-mutated cohort. This evidence concerns the gene BRAF and neoplasm.